Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 20 | 2025 | 634 | 5.020 |
Why?
|
| Carcinoma, Squamous Cell | 13 | 2023 | 785 | 2.430 |
Why?
|
| Diagnostic Imaging | 7 | 2022 | 315 | 1.870 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2025 | 2190 | 1.850 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2025 | 3869 | 1.550 |
Why?
|
| Mouth Neoplasms | 5 | 2020 | 99 | 1.510 |
Why?
|
| Neoplasm Recurrence, Local | 9 | 2025 | 1310 | 1.350 |
Why?
|
| Positron Emission Tomography Computed Tomography | 6 | 2022 | 79 | 1.310 |
Why?
|
| Oropharyngeal Neoplasms | 7 | 2023 | 285 | 1.250 |
Why?
|
| Neck | 6 | 2025 | 143 | 1.190 |
Why?
|
| Image-Guided Biopsy | 2 | 2020 | 44 | 1.150 |
Why?
|
| Radiology | 5 | 2025 | 126 | 1.130 |
Why?
|
| Radiology Information Systems | 4 | 2025 | 26 | 1.090 |
Why?
|
| Papillomavirus Infections | 5 | 2023 | 398 | 0.910 |
Why?
|
| Lymphatic Metastasis | 3 | 2025 | 450 | 0.780 |
Why?
|
| Tongue | 3 | 2021 | 34 | 0.610 |
Why?
|
| Mouth | 2 | 2016 | 72 | 0.590 |
Why?
|
| Patient Access to Records | 1 | 2017 | 14 | 0.560 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 675 | 0.540 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 379 | 0.540 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2016 | 13 | 0.510 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 134 | 0.510 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 414 | 0.500 |
Why?
|
| Sensitivity and Specificity | 10 | 2025 | 2153 | 0.500 |
Why?
|
| Patient Preference | 1 | 2017 | 135 | 0.500 |
Why?
|
| Positron-Emission Tomography | 4 | 2022 | 312 | 0.450 |
Why?
|
| Humans | 56 | 2025 | 133505 | 0.440 |
Why?
|
| Neoplasm Staging | 8 | 2022 | 1374 | 0.440 |
Why?
|
| Contrast Media | 5 | 2022 | 518 | 0.430 |
Why?
|
| Neuroimaging | 1 | 2017 | 375 | 0.420 |
Why?
|
| Communication | 1 | 2017 | 541 | 0.410 |
Why?
|
| Neoplasms, Unknown Primary | 3 | 2021 | 15 | 0.390 |
Why?
|
| Temporomandibular Joint | 1 | 2012 | 10 | 0.390 |
Why?
|
| Research Design | 3 | 2022 | 756 | 0.380 |
Why?
|
| Middle Aged | 21 | 2025 | 29066 | 0.370 |
Why?
|
| Laryngeal Neoplasms | 3 | 2022 | 94 | 0.370 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2012 | 51 | 0.360 |
Why?
|
| Fellowships and Scholarships | 3 | 2025 | 323 | 0.360 |
Why?
|
| Retrospective Studies | 17 | 2025 | 17564 | 0.350 |
Why?
|
| Pseudotumor Cerebri | 1 | 2012 | 69 | 0.350 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 3042 | 0.340 |
Why?
|
| Central Nervous System Infections | 1 | 2010 | 22 | 0.340 |
Why?
|
| Optic Neuritis | 1 | 2010 | 35 | 0.330 |
Why?
|
| Opportunistic Infections | 1 | 2010 | 80 | 0.330 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 1037 | 0.320 |
Why?
|
| Aged | 17 | 2025 | 21572 | 0.310 |
Why?
|
| Carcinoma | 1 | 2012 | 308 | 0.310 |
Why?
|
| Optic Nerve Diseases | 1 | 2010 | 86 | 0.310 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 259 | 0.300 |
Why?
|
| Lymphoma | 1 | 2012 | 334 | 0.300 |
Why?
|
| Lymph Nodes | 2 | 2025 | 397 | 0.300 |
Why?
|
| Central Nervous System Diseases | 1 | 2009 | 109 | 0.290 |
Why?
|
| Adult | 17 | 2025 | 31766 | 0.280 |
Why?
|
| Calcinosis | 1 | 2009 | 190 | 0.270 |
Why?
|
| Male | 23 | 2025 | 65641 | 0.270 |
Why?
|
| Larynx | 2 | 2022 | 78 | 0.270 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 234 | 0.250 |
Why?
|
| Female | 25 | 2025 | 71531 | 0.240 |
Why?
|
| Neuroradiography | 1 | 2025 | 5 | 0.240 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 2311 | 0.230 |
Why?
|
| Population Surveillance | 2 | 2018 | 416 | 0.220 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 1973 | 0.220 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2003 | 11 | 0.210 |
Why?
|
| Skull Base | 3 | 2022 | 52 | 0.200 |
Why?
|
| Tongue Neoplasms | 1 | 2003 | 30 | 0.200 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 7191 | 0.200 |
Why?
|
| Education, Medical, Graduate | 2 | 2025 | 567 | 0.200 |
Why?
|
| Angiography | 1 | 2003 | 212 | 0.190 |
Why?
|
| Gadolinium | 2 | 2015 | 117 | 0.190 |
Why?
|
| Radiologists | 1 | 2022 | 51 | 0.190 |
Why?
|
| Image Enhancement | 1 | 2003 | 174 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2020 | 118 | 0.180 |
Why?
|
| Radiography | 4 | 2022 | 822 | 0.180 |
Why?
|
| Prognosis | 4 | 2022 | 5052 | 0.180 |
Why?
|
| Radiation Oncology | 1 | 2021 | 28 | 0.180 |
Why?
|
| Papillomaviridae | 2 | 2022 | 188 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1344 | 0.170 |
Why?
|
| Skull Base Neoplasms | 1 | 2021 | 42 | 0.170 |
Why?
|
| Narrow Band Imaging | 1 | 2020 | 2 | 0.170 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 34 | 0.170 |
Why?
|
| Subcutaneous Emphysema | 1 | 2020 | 3 | 0.170 |
Why?
|
| Mediastinal Emphysema | 1 | 2020 | 11 | 0.170 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 51 | 0.170 |
Why?
|
| Curriculum | 2 | 2025 | 766 | 0.160 |
Why?
|
| Emphysema | 1 | 2020 | 67 | 0.160 |
Why?
|
| Neurology | 1 | 2021 | 120 | 0.150 |
Why?
|
| Tonsillectomy | 1 | 2021 | 110 | 0.150 |
Why?
|
| Tobacco Smoking | 1 | 2018 | 20 | 0.150 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 1467 | 0.150 |
Why?
|
| Brain | 1 | 2010 | 3220 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 361 | 0.140 |
Why?
|
| Young Adult | 7 | 2020 | 9967 | 0.140 |
Why?
|
| Referral and Consultation | 2 | 2021 | 573 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2022 | 397 | 0.130 |
Why?
|
| Physician's Role | 1 | 2017 | 171 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2021 | 1069 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2018 | 373 | 0.120 |
Why?
|
| Georgia | 2 | 2013 | 39 | 0.120 |
Why?
|
| Chemoradiotherapy | 3 | 2022 | 126 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1305 | 0.120 |
Why?
|
| Myelography | 1 | 2015 | 9 | 0.120 |
Why?
|
| Branchioma | 1 | 2014 | 3 | 0.120 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2015 | 45 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2017 | 823 | 0.110 |
Why?
|
| Injections, Spinal | 1 | 2015 | 136 | 0.110 |
Why?
|
| Facial Nerve | 1 | 2014 | 26 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 45 | 0.110 |
Why?
|
| Neck Dissection | 1 | 2014 | 31 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 616 | 0.110 |
Why?
|
| Headache | 1 | 2014 | 109 | 0.100 |
Why?
|
| Empty Sella Syndrome | 1 | 2013 | 1 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2017 | 1463 | 0.100 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 106 | 0.100 |
Why?
|
| Thyroid Cartilage | 1 | 2012 | 5 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2022 | 1250 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 3989 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2022 | 13089 | 0.090 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 134 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 261 | 0.090 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 211 | 0.090 |
Why?
|
| Histoplasmosis | 1 | 2010 | 49 | 0.080 |
Why?
|
| Sinusitis | 1 | 2011 | 114 | 0.080 |
Why?
|
| Mycoses | 1 | 2011 | 117 | 0.080 |
Why?
|
| Basal Ganglia | 1 | 2010 | 63 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2013 | 278 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5451 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2018 | 6585 | 0.080 |
Why?
|
| Temporal Lobe | 1 | 2010 | 118 | 0.080 |
Why?
|
| Incidence | 2 | 2021 | 3393 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 472 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 313 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2013 | 527 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 349 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1730 | 0.070 |
Why?
|
| Adolescent | 6 | 2020 | 20586 | 0.060 |
Why?
|
| Accreditation | 1 | 2025 | 94 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 1078 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2010 | 717 | 0.050 |
Why?
|
| Oral Hemorrhage | 1 | 2003 | 3 | 0.050 |
Why?
|
| United States | 3 | 2025 | 11759 | 0.050 |
Why?
|
| Laryngectomy | 1 | 2022 | 34 | 0.050 |
Why?
|
| Trigeminal Nerve | 1 | 2022 | 6 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 37 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 781 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2021 | 59 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2025 | 981 | 0.040 |
Why?
|
| Head | 1 | 2021 | 114 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 256 | 0.040 |
Why?
|
| SEER Program | 1 | 2021 | 222 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 276 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 168 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 132 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 517 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 147 | 0.040 |
Why?
|
| HIV Infections | 1 | 2010 | 2023 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 965 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1136 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 740 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 148 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 1270 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 93 | 0.030 |
Why?
|
| Cerebral Revascularization | 1 | 2013 | 22 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 107 | 0.020 |
Why?
|
| Learning Curve | 1 | 2013 | 57 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2955 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 258 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 318 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 306 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3725 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 732 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3168 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2016 | 14895 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 3448 | 0.010 |
Why?
|
| Child | 2 | 2016 | 25874 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 6544 | 0.010 |
Why?
|